335 related articles for article (PubMed ID: 19428940)
1. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase.
Takeda S; Yamamoto I; Watanabe K
Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940
[TBL] [Abstract][Full Text] [Related]
2. Delta(9)-Tetrahydrocannabinol enhances MCF-7 cell proliferation via cannabinoid receptor-independent signaling.
Takeda S; Yamaori S; Motoya E; Matsunaga T; Kimura T; Yamamoto I; Watanabe K
Toxicology; 2008 Mar; 245(1-2):141-6. PubMed ID: 18249480
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
4. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
[TBL] [Abstract][Full Text] [Related]
5. Delta(9)-tetrahydrocannabinol inhibits 17beta-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells.
von Bueren AO; Schlumpf M; Lichtensteiger W
Anticancer Res; 2008; 28(1A):85-9. PubMed ID: 18383828
[TBL] [Abstract][Full Text] [Related]
6. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
[TBL] [Abstract][Full Text] [Related]
7. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription.
Khare M; Taylor AH; Konje JC; Bell SC
Mol Hum Reprod; 2006 May; 12(5):321-33. PubMed ID: 16597638
[TBL] [Abstract][Full Text] [Related]
8. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
9. JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells.
Caffarel MM; Moreno-Bueno G; Cerutti C; Palacios J; Guzman M; Mechta-Grigoriou F; Sanchez C
Oncogene; 2008 Aug; 27(37):5033-44. PubMed ID: 18454173
[TBL] [Abstract][Full Text] [Related]
10. Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
Preet A; Ganju RK; Groopman JE
Oncogene; 2008 Jan; 27(3):339-46. PubMed ID: 17621270
[TBL] [Abstract][Full Text] [Related]
11. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
Caffarel MM; Sarrió D; Palacios J; Guzmán M; Sánchez C
Cancer Res; 2006 Jul; 66(13):6615-21. PubMed ID: 16818634
[TBL] [Abstract][Full Text] [Related]
12. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis.
Sarafian TA; Tashkin DP; Roth MD
Toxicol Appl Pharmacol; 2001 Aug; 174(3):264-72. PubMed ID: 11485387
[TBL] [Abstract][Full Text] [Related]
13. Melatonin modulates aromatase activity in MCF-7 human breast cancer cells.
Cos S; Martínez-Campa C; Mediavilla MD; Sánchez-Barceló EJ
J Pineal Res; 2005 Mar; 38(2):136-42. PubMed ID: 15683469
[TBL] [Abstract][Full Text] [Related]
14. Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells.
Horia E; Watkins BA
Carcinogenesis; 2007 Apr; 28(4):809-15. PubMed ID: 17052999
[TBL] [Abstract][Full Text] [Related]
15. Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E₂ production in human endometriotic stromal cells in spheroid culture.
Yamanaka K; Xu B; Suganuma I; Kusuki I; Mita S; Shimizu Y; Mizuguchi K; Kitawaki J
Fertil Steril; 2012 Feb; 97(2):477-82. PubMed ID: 22130322
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
[TBL] [Abstract][Full Text] [Related]
17. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
18. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Macedo LF; Guo Z; Tilghman SL; Sabnis GJ; Qiu Y; Brodie A
Cancer Res; 2006 Aug; 66(15):7775-82. PubMed ID: 16885381
[TBL] [Abstract][Full Text] [Related]
19. 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway.
Yuan L; Jiang R; Yang Y; Ding S; Deng H
Oncol Rep; 2012 Dec; 28(6):2131-7. PubMed ID: 22971613
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.
Duan W; Zhang L
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):317-21. PubMed ID: 16618538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]